|
Agenda |
| |
08:00 | Registration |
09:20 |  | Keynote Presentation Opening Talk
Utpal Tatu, Professor, Indian Institute of Science Bangalore, India
|
|
|
Session I: Recent Advances in Metabolic Identification |
| |
09:40 | Metabolite Identification: An Art of Structure Elucidation using Mass Spectrometry
Lakshmikant Bajpai, Deputy Research Director, Syngene International Ltd , India
|
10:10 | Gut Microbial Degradation of OP-Insecticides-Induces Glucose Homeostatic Dysfunctions
Ramasamy Subbiah, Assistant Professor, Madurai Kamaraj University, India
|
10:40 | Coffee Break and Networking in Exhibition Area |
|
Session II: Metabolite Screening - Clinical Applications |
| |
11:10 | Understanding Complex Lipid Metabolism through Quantitative Lipidomics
Baljit Ubhi, Global Staff Scientist, Sciex, United States of America
In this talk novel, quantitative lipid screening platform allowing a complete solution for understanding complex lipid metabolism will be presented. |
11:40 | Hepatocytes, Spheroids & Enterocytes: Tools for Studying Toxicity and Metabolism
Deepak Barot, Director, In Vitro ADMET Laboratories, LLC., United States of America
|
12:10 | Metabolite in Safety Testing (MIST): De-risking Clinical Candidates
Sanjeev Giri, Associate Research Director, Aurigene Discovery Technologies, India
|
12:40 | Lunch Break and Networking in Exhibition Area |
|
Session III: Metabolomics in Drug Discovery |
| |
13:35 |  | Keynote Presentation Genome-Scale Metabolic Modelling and Insights to Drug Discovery
Nagasuma Chandra, Professor, Indian Institute of Science, India
|
|
14:20 | Reactive Metabolites and their Implications on Drug Discovery
Ravi Shankara, Senior Manager - R & D, Sun Pharma Advanced Research Company Ltd, India
|
14:50 | Early Human Toxicity Screening Strategies during Drug Discovery in the 21st Century to prevent Adverse Drug Reactions
G Praveen Kumar, Professor & Principal, Sahasra Institute of Pharmaceutical Sciences, India
|
15:20 | Coffee Break and Networking in Exhibition Area |
|
Session IV: Leveraging Mass Spectrometry for Clinical Metabolomics |
| |
15:35 | Metabolomics of Nosocomial Infections in the Intensive Care Unit (ICU)
Dipankar Ghosh, Assistant Professor, Jawaharlal Nehru University, India
|
16:05 | Metabolomic Approach for Diagnosis of Inborn Errors of Metabolism (IEMs) using Mass Spectrometry
Usha Dave, Director, MILS International India, India
This talk describes the use of Tandem mass spectrometry (TMS) and GC/MS for diagnosis of Inborn Error Metabolism. The specific biomarkers for an individual IEM with their characteristic m/z ions during fragmentation for confirming the diagnosis will also be discussed. In this presentation, few IEMs such as MMA, MSUD, GA type-I, Beta-Ketothiolase deficiency, Canavan Disease etc. will be described. |
16:35 |  Technology Spotlight:
Mass Spectrometry as a Tool for Disease Metabolite Studies
Ajit Datar, Advisor, Shimadzu Analytical (India) Pvt Ltd
|
16:50 | Quantization of Fentanyl by GC-MS in Post operative Samples
Bharat Venkatesh, Junior Scientific Officer, National Institute of Mental Health and Neurosciences, India
|
17:05 | Cotinine Quantification among Smokers, Passive Smokers and Non Smokers using LCMS-MS
Niharika Sane, Research Scholar, NIMHANS, India
|
17:20 | Screening and Quantification of Hippuric acid as a Marker of Solvent Exposure using LCMS-MS
Chowdaiah M, PhD Scholar , NIMHANS, India
|
17:35 | End of Conference |
 (1).jpg)